Search

Nuclear logging is one of major areas of logging development. This paper presents an empirical investigation to bring the drilling and completion of wells from an ill-defined art to a refined sci-ence by using radioactive source to “look and measure” such as formation type, formation dip, porosity, fluid type and numerous other important factors. The initial nuclear logging tools rec-ords the radiation emitted by formation as they were crossed by boreholes. Gamma radiation is used in well logging as it is powerful enough to penetrate the formation and steel casing. The ra-dioactive source is reusable so that after engineer finished the job the radioactive source is sent back to bunker. In this case inventory level of radioactive source is relatively high compared with monthly movement and the company must spend large amount of cost just for inventory. After calculating and averaging the monthly movement in 2014 and 2015, we detected a big pos-sibility to cut the inventory level to reduce the inventory cost.

The majority of known peptides with high bioactivity (BAPs) such as antihypertensive, antidiabetic, antioxidant, hypocholesterolemic, anti-inflammatory and antimicrobial actions, are short-chain sequences of less than ten amino acids. These short-chain BAPs of varying natural and synthetic origin must be bioaccessible to be capable of being adsorbed systemically upon oral administration to show their full range of bioactivity. However, in general, in vitro and in vivo studies have shown that gastrointestinal digestion reduces BAPs bioactivity unless they are protected from degradation by encapsulation. This review gives a critical analysis of short-chain BAP encapsulation and performance with regard to the oral delivery route. In particular, it focuses on short-chain BAPs with antihypertensive and antidiabetic activity and encapsulation methods via nanoparticles and microparticles. Also addressed are the different wall materials used to form these particles and their associated payloads and release kinetics, along with the current challenges and a perspective of the future applications of these systems.

The current study aims to determine the inhibition activity gelatin against dipeptidyl aminopeptidase 4 (DP-4). Two commercial gelatins, i.e., bovine and fish skin gelatin and one extracted (in our laboratory) gelatin, i.e., fish bone gelatin were selected for analysis. Each gelatin have same protein pattern (75-245 kDa) on sodium dodecyl sulfate polyacrylamide gel electrophoresis with mean of protein concentration of 1.72 mg/mL. The inhibition activity was measured on the capacity to inhibit DP-4 by using Gly-Pro-p-nitroanilide as their substrate. The sitagliptin was used as standard comparison. Based on the percent inhibition, gelatin has been shown to be the prospective DP-4 inhibitor.